HI
CELG

Human Investing’s Celgene Corp CELG Stock Holding History

Human Investing’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,033
Closed -$202K – 408
2019
Q3 		$202K Buy
2,033
+12
+0.6% +$1.14K 0.07% 106
2019
Q2 		$187K Sell
2,021
-19
-0.9% -$1.8K 0.07% 112
2019
Q1 		$192K Buy
2,040
+75
+4% +$6.56K 0.07% 108
2018
Q4 		$126K Buy
+1,965
New +$145K 0.05% 131

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Human Investing's CELG Position: Q4 2019 in Review

Human Investing sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,033 shares — an estimated $202K sold.

Human Investing first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $202K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Human Investing reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Human Investing sold 2,033 Celgene Corp shares in Q4 2019, an estimated $202K.
  • Human Investing first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
  • Human Investing's Celgene Corp position peaked at $202K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Human Investing's 13F filing for Q4 2019, filed 7 Feb 2020.